申请人:DAIICHI PHARMACEUTICAL CO., LTD.
公开号:US20030232808A1
公开(公告)日:2003-12-18
Described is a sulfonyl derivative represented by the following formula (I):
1
[wherein R
1
represents a hydrogen atom, a hydroxyl group, a nitro group or the like, R
2
and R
3
each independently represents a hydrogen atom, a halogen atom or the like, R
4
and R
5
each independently represents a hydrogen atom, a halogen atom or the like, Q
1
represents a saturated or unsaturated 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like, Q
2
represents a single bond, an oxygen atom or the like, Q
3
represents any one of the following groups:
2
T
1
represents a carbonyl group or the like, and X
1
and X
2
each independently represents a methine group or a nitrogen atom]; or salt thereof; or solvate thereof. The sulfonyl derivative, salt or solvate according to the present invention is novel as an excellent anticoagulant and it has strong FXa inhibitory action, rapidly exhibits sufficient and long-lasting anti-thrombus effects after oral administration and has less side effects.
本发明涉及一种磺酰基衍生物,其表示为以下式子(I):1[其中,R1代表氢原子、羟基、硝基或类似物,R2和R3各自独立地代表氢原子、卤素原子或类似物,R4和R5各自独立地代表氢原子、卤素原子或类似物,Q1代表饱和或不饱和的5或6元环烃基,可以被取代,或类似物,Q2代表单键、氧原子或类似物,Q3代表以下任意一种基团:2T1代表羰基或类似物,X1和X2各自独立地代表亚甲基基团或氮原子];或其盐;或其溶剂化物。根据本发明的磺酰基衍生物,盐或溶剂化物作为一种优异的抗凝血剂是新颖的,具有强烈的FXa抑制作用,在口服后迅速表现出足够持久的抗血栓效果,并且副作用较少。